EP1603554A1 - METHOD FOR INCREASING THE ORAL BIOAVAILABILITY OF S-[2-([[1-(2-ETHYLBUTYL)CYCLOHEXYL]CARBONYL]AMINO)PHENYL]-2-METHYLPROPANETHIOATE